Unassigned Industry (438) | License Agreements (1,536)

Browse by Company

4D Molecular Therapeutics Inc (4)
908 Devices Inc. (6)
AbCellera Biologics Inc. (4)
Acutus Medical, Inc. (6)
ADiTx Therapeutics, Inc. (1)
Aevi Genomic Medicine, Inc. (5)
Akouos, Inc. (1)
Akoya Biosciences, Inc. (3)
Alfacourse Inc. (1)
Aligos Therapeutics, Inc. (4)
Allovir, Inc. (3)
Alpha Healthcare Acquisition Corp. (9)
AMERICAN INTERNATIONAL HOLDINGS CORP. (1)
AMMO, INC. (1)
Anebulo Pharmaceuticals, Inc. (1)
AppTech Corp. (4)
AquaMed Technologies, Inc. (6)
ARATANA THERAPEUTICS, INC. (1)
ArcherDX, Inc. (4)
Ardent Health Partners, LLC (1)
Artiva Biotherapeutics, Inc. (6)
ATAI Life Sciences B.V. (3)
Atea Pharmaceuticals, Inc. (1)
AVEDRO INC (2)
AYTU BIOSCIENCE, INC (6)
AZIYO BIOLOGICS, INC. (2)
BAKER HUGHES a GE Co LLC (2)
Berkeley Lights, Inc. (2)
BioAtla, Inc. (4)
BIODESIX INC (2)
Burgundy Technology Acquisition Corp (1)
C4 Therapeutics, Inc. (3)
CannAssist International Corp (1)
Cell Source, Inc. (2)
Centessa Pharmaceuticals Ltd (4)
Century Therapeutics, Inc. (8)
CMI Acquisition, LLC (3)
Conatus Pharmaceuticals Inc. (6)
COSMO VENTURES INC (7)
CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (1)
Cullinan Oncology, LLC (3)
Darkstar Ventures, Inc. (1)
Day One Biopharmaceuticals Holding Co LLC (3)
Decibel Therapeutics, Inc. (4)
Dermavant Sciences Ltd (10)
Dermira, Inc. (2)
Design Therapeutics, Inc. (1)
Digital Development Partners, Inc. (1)
Dyne Therapeutics, Inc. (1)
Egalet Corp (3)
Elevation Oncology, Inc. (1)
Esports Technologies, Inc. (3)
EzFill Holdings Inc (1)
FairWind Energy Inc. (1)
Fibrocell Science, Inc. (1)
Finch Therapeutics Group, Inc. (3)
Folkup Development Inc. (4)
Forma Therapeutics Holdings, Inc., (2)
Freecast, Inc. (2)
Fusion Acquisition Corp. (1)
Fusion Pharmaceuticals Inc. (2)
Gene Biotherapeutics, Inc. (3)
Glolex, Inc. (3)
Glucose Biosensor Systems (Greater China) Holdings, Inc. (7)
GOLDENWELL BIOTECH, INC. (2)
Gordon Pointe Acquisition Corp. (1)
Grail, Inc. (5)
Graphite Bio, Inc. (4)
GRAYBUG VISION, INC. (1)
Greenwich LifeSciences, Inc. (3)
HCW Biologics Inc. (1)
Holly Brothers Pictures, Inc. (2)
IASO BioMed, Inc. (1)
Ikena Oncology, Inc. (2)
Immunome Inc. (1)
IN8BIO, INC. (8)
Inhibikase Therapeutics, Inc. (1)
Inhibrx, Inc. (7)
Inozyme Pharma, Inc. (1)
Intellisense Solutions Inc. (1)
JANGIT ENTERPRISES, INC. (1)
Janux Therapeutics, Inc. (1)
Jupiter Wellness, Inc. (1)
Kiromic Biopharma, Inc. (4)
Kubient, Inc. (1)
Laird Superfood, Inc. (1)
Locust Walk Acquisition Corp. (1)
Longboard Pharmaceuticals, Inc. (1)
LONGEVERON LLC (5)
Lucira Health, Inc. (1)
Lyell Immunopharma, Inc. (1)
Megalith Financial Acquisition Corp (1)
Mellanox Technologies, Ltd. (1)
Metacrine, Inc. (1)
Miromatrix Medical Inc. (19)
Monte Rosa Therapeutics, Inc. (1)
MORGAN GROUP HOLDING CO (1)
Morphic Holding, Inc. (2)
MOTORSPORT GAMING US LLC (9)
Neon Therapeutics, Inc. (2)
NEUROTROPE BIOSCIENCE, INC. (3)
New Providence Acquisition Corp. (1)
NexImmune, Inc. (1)
Nkarta, Inc. (1)
NOVELION THERAPEUTICS INC. (1)
Ocean Biomedical, Inc. (1)
Odyssey Group International, Inc. (1)
Oncorus, Inc. (6)
Pactiv Evergreen Inc. (1)
PaxMedica, Inc. (4)
Pelican Delivers, Inc. (1)
Peloton Therapeutics, Inc. (1)
Peninsula Acquisition Corp (1)
Petros Pharmaceuticals, Inc. (1)
Pharos Capital BDC, Inc. (1)
Poseida Therapeutics, Inc. (10)
Praxis Precision Medicines, Inc. (2)
Prelude Therapeutics Inc (2)
Pro Music Rights, Inc (4)
Prometheus Biosciences, Inc. (4)
PUBMATIC, INC. (1)
Ra Pharmaceuticals, Inc. (1)
Rain Therapeutics Inc. (2)
RECURSION PHARMACEUTICALS, INC. (3)
Reneo Pharmaceuticals, Inc. (1)
Repare Therapeutics Inc. (1)
REVA Medical, Inc. (1)
RMG Acquisition Corp. (1)
Roth CH Acquisition I Co. Parent Corp. (1)
Sagimet Biosciences Inc. (1)
Sana Biotechnology, Inc. (17)
Sandbridge Acquisition Corp (1)
Seer, Inc. (1)
Sensei Biotherapeutics, Inc. (1)
SeqLL, Inc. (1)
Shattuck Labs, Inc. (1)
Sigilon Therapeutics, Inc. (5)
Silverback Therapeutics, Inc. (2)
Singular Genomics Systems, Inc. (1)
SMARTHEAT INC. (1)
Spark Therapeutics, Inc. (1)
Spinal Elements Holdings, Inc. (1)
SPRUCE BIOSCIENCES, INC. (1)
SQZ Biotechnologies Co (1)
Synthorx, Inc. (1)
Talaris Therapeutics, Inc. (1)
Tarsus Pharmaceuticals, Inc. (4)
TAURIGA SCIENCES, INC. (1)
Taysha Gene Therapies, Inc. (3)
Terns Pharmaceuticals, Inc. (3)
Therapeutics Acquisition Corp. (1)
Transcode Therapeutics, Inc. (2)
TScan Therapeutics, Inc. (3)
Unicycive Therapeutics, Inc. (1)
UNITED STATES CELLULAR CORP (1)
United States Commodity Index Funds Trust (1)
United States Gold & Treasury Investment Trust (1)
Vaccitech plc (4)
Vallon Pharmaceuticals, Inc. (1)
VapAria Corp (1)
Vera Therapeutics, Inc. (1)
Verve Therapeutics, Inc. (2)
Virios Therapeutics, LLC (1)
Virpax Pharmaceuticals, Inc. (6)
Vivakor, Inc. (2)
Vontier Corp (2)
Vor Biopharma Inc. (3)
Webstar Technology Group Inc. (1)
Werewolf Therapeutics, Inc. (1)
WEWARDS, INC. (1)
WORLD HEALTH ENERGY HOLDINGS, INC. (1)
WU BA SUPERIOR PRODUCTS HOLDING GROUP INC. (1)
Zander Therapeutics, Inc (1)

Recent Contracts

License Agreement, dated June 16, 2021 (Jupiter Wellness, Inc., Filed With SEC on June 17, 2021)
License Agreement (Reprogramming), by and between Century Therapeutics, Inc. and FUJIFILM Cellular Dynamics, Inc., dated September 18, 2018 (Century Therapeutics, Inc., Filed With SEC on June 15, 2021)
License Agreement (Differentiation), by and between Century Therapeutics, Inc. and FUJIFILM Cellular Dynamics, Inc., dated September 18, 2018 (Century Therapeutics, Inc., Filed With SEC on June 15, 2021)
Exclusive License Agreement, dated May 9, 2013, by and between eFFECTOR and the Regents of the University of California (Locust Walk Acquisition Corp., Filed With SEC on June 14, 2021)
License Agreement by and between the Registrant and Integrated DNA Technologies, Inc., dated June 7, 2021 (Graphite Bio, Inc., Filed With SEC on June 11, 2021)
Nonexclusive License Agreement for COVID-19 Related Technology, dated as of June 25, 2020, by and between the Registrant and The Board of Trustees of the Leland Stanford Junior... (Ocean Biomedical, Inc., Filed With SEC on June 9, 2021)
Exclusive License Agreement by and between the Company and Sphaera Pharma Pte. Ltd., dated October 1, 2017 (Unicycive Therapeutics, Inc., Filed With SEC on June 7, 2021)
Commercial License Agreement dated June 4, 2008 between Selexis SA and Merrimack Pharmaceuticals, Inc (Elevation Oncology, Inc., Filed With SEC on June 4, 2021)
Exclusive License Agreement by and between the Registrant and The Board of Trustees of the Leland Stanford Junior University, dated December 7, 2020 (Graphite Bio, Inc., Filed With SEC on June 4, 2021)
Amendment No. 1 to the Exclusive License Agreement by and between the Registrant and The Board of Trustees of the Leland Stanford Junior University, dated March 4, 2021 (Graphite Bio, Inc., Filed With SEC on June 4, 2021)